Biopharmaceutical company licensing and developing drugs to treat fibrosis.
- Year invested 2015
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Website reneopharma.com/
- Company Status IPO/Public (NASDAQ: RPHM)
Biopharmaceutical company licensing and developing drugs to treat fibrosis.